For Whom the Trial is Intended?
The VIABLE clinical trial is intended for patients with metastatic castration-resistant prostate cancer (see the section entitled Prostate Cancer), who meet the entry criteria in the screening phase. They must have signed a Consent Form after receiving a full explanation of the trial and given adequate time to consider the Patient Information Leaflet. The Patient Information Leaflet and signing of the Consent Form confirms the patients understand the procedures and they voluntarily enter the clinical trial.
Consideration and entry to the trial will be a suggestion of the patient’s physician and will not impede their standard of care or treatment whether they participate or not.